Loading...
Loading...
Key Banc lowers its rating on HCP
HCP to Underweight from Hold and established a downside price target of $34 on continued sector risks.
Key Banc says, "Despite easing uncertainty in the health care regulatory environment in the near term, we continue to see risks to health care real estate valuations as the political will to cut health care spending remains a risk. Additionally, we see more attractive organic growth in sectors with more leverage to an improving economy. While we acknowledge the above average
rent growth embedded in HCP's senior housing (29% of NOI) and skilled nursing facilities (38%) as a result of lease transitions (to Emeritus and Brookdale) and its HCR ManorCare acquisition, we view this growth as fully priced into the stock today."
HCP closed at $24.52 per share on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in